Zimmer Biomet Reports Positive Study Results with nSTRIDE APS in Knee OA

Zimmer Biomet announced positive results in PROGRESS II, a pilot study, demonstrating safety and promising efficacy from use of the nSTRIDE® Autologous Protein Solution (APS) Kit to treat knee osteoarthritis (OA).

Specifically, results indicate that the solution, which was prepared with the nSTRIDE kit, may be a viable treatment for knee OA....

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us